Litigation Details for Novartis Pharmaceuticals Corporation v. Teva Pharmaceuticals USA, Inc. (D. Del. 2018)
✉ Email this page to a colleague
Novartis Pharmaceuticals Corporation v. Teva Pharmaceuticals USA, Inc. (D. Del. 2018)
Docket | ⤷ Sign Up | Date Filed | 2018-07-13 |
Court | District Court, D. Delaware | Date Terminated | 2019-03-19 |
Cause | 35:1 Patent Infringement | Assigned To | Leonard Philip Stark |
Jury Demand | None | Referred To | |
Patents | 9,187,405 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Novartis Pharmaceuticals Corporation v. Teva Pharmaceuticals USA, Inc.
Details for Novartis Pharmaceuticals Corporation v. Teva Pharmaceuticals USA, Inc. (D. Del. 2018)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
0000-00-00 | 39 | Consolidated Invalidity Contentions Regarding U.S. Patent No. 9,187,405 filed by HEC Pharm Co., Ltd., HEC Pharm …2018 19 March 2019 1:18-cv-01039 835 Patent - Abbreviated New Drug Application(ANDA) | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |